These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16951184

  • 1. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
    Leibowitz-Amit R, Tsarfaty G, Abargil Y, Yerushalmi GM, Horev J, Tsarfaty I.
    Cancer Res; 2006 Sep 01; 66(17):8687-97. PubMed ID: 16951184
    [Abstract] [Full Text] [Related]

  • 2. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.
    Yerushalmi GM, Leibowitz-Amit R, Shaharabany M, Tsarfaty I.
    Neoplasia; 2002 Sep 01; 4(6):510-22. PubMed ID: 12407445
    [Abstract] [Full Text] [Related]

  • 3. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
    Firon M, Shaharabany M, Altstock RT, Horev J, Abramovici A, Resau JH, Vande Woude GF, Tsarfaty I.
    Oncogene; 2000 May 11; 19(20):2386-97. PubMed ID: 10828880
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 11; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 5. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
    Accornero P, Martignani E, Macchi E, Baratta M.
    J Dairy Sci; 2007 Sep 15; 90(9):4289-96. PubMed ID: 17699048
    [Abstract] [Full Text] [Related]

  • 7. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL, Cardelli JA.
    Oncogene; 2006 Mar 23; 25(13):1922-30. PubMed ID: 16449979
    [Abstract] [Full Text] [Related]

  • 8. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Mar 23; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 10. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA, Vargas M, Soares CR, Holzer RG, Ide AE, Jorcyk CL.
    Prostate; 2005 Jul 01; 64(2):139-48. PubMed ID: 15678502
    [Abstract] [Full Text] [Related]

  • 11. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov 01; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H, Naujokas MA, Park M.
    Cell Growth Differ; 1994 Apr 01; 5(4):359-66. PubMed ID: 8043510
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 01; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner.
    Crostella L, Lidder S, Williams R, Skouteris GG.
    Oncogene; 2001 Jun 21; 20(28):3735-45. PubMed ID: 11439336
    [Abstract] [Full Text] [Related]

  • 19. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW, Vande Woude GF.
    J Cell Biochem; 2003 Feb 01; 88(2):408-17. PubMed ID: 12520544
    [Abstract] [Full Text] [Related]

  • 20. Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
    Xie Q, Gao CF, Shinomiya N, Sausville E, Hay R, Gustafson M, Shen Y, Wenkert D, Vande Woude GF.
    Oncogene; 2005 May 26; 24(23):3697-707. PubMed ID: 15782129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.